Tenon MedicalTNON -10.39%38 FCF Yield % is -331.80 as of Jul. 05, 2026. GuruFocus rates TNON with a GF Score™ of 38/100 and a GF Value™ of $0.35 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 857 Medical Devices & Instruments companies, Tenon Medical ranks worse than 98.13% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Tenon Medical FCF Yield % Related Terms
Tenon Medical FCF Yield % Historical Data
* Premium members only.
The historical data trend for Tenon Medical's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Tenon Medical's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tenon Medical FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tenon Medical's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Tenon Medical's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tenon Medical (TNON) has a FCF Yield % of -331.80 as of Jul. 05, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tenon Medical and its competitors. According to the industry distribution chart, Tenon Medical ranks #841 out of 857 companies in the Medical Devices & Instruments industry, placing it in the top 98.1%.
Is Tenon Medical's FCF Yield % too high?
Tenon Medical's current FCF Yield % is -331.80. Based on the distribution chart, Tenon Medical ranks #841 out of 857 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Tenon Medical has a GF Score™ of 38/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tenon Medical's FCF Yield % compare to XAIR and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Tenon Medical ranks #841 out of 857 companies for FCF Yield %. This places Tenon Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Tenon Medical and its competitors. Tenon Medical's current FCF Yield % is -331.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tenon Medical stock overvalued right now?
Based on GuruFocus' analysis, Tenon Medical (TNON) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.35, compared to a current price of $0.29 — trading 18% below its estimated fair value. The current FCF Yield % is -331.80. Tenon Medical's overall GF Score™ is 38/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Tenon Medical (TNON), the current FCF Yield % is -331.80 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tenon Medical (TNON) Overvalued in 2026?
Based on GuruFocus' analysis, Tenon Medical stock appears to be undervalued.
The current stock price of $0.29 is trading 18% below its estimated GF Value™ of $0.35.
GuruFocus considers Tenon Medical to be Modestly Undervalued.
Key valuation signals for TNON:
FCF Yield %: -331.80
GF Value™: $0.35 vs. price of $0.29 (18% below fair value)
No single metric tells the full story. See the TNON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tenon Medical Inc is a medical device company that has minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities; Primary SI Joint procedures, Revision procedures of failed SI Joint implants, and SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.
38GF Score
Get the complete analysis for TNON
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TNON has been successfully added to your 
